Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma Radiation dose received by the ...
Survival disparities and trend of head and neck cancer in the United States: A Surveillance, Epidemiology, and End Results (SEER) database study 1973-2010. This is an ASCO Meeting Abstract from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results